[1] Eversole LR, Siar CH, Vander WI, et al.Primary intraosseous squamous cell carcinomas in pathology & genetics: head and neck tumors WHO classification, head and neck tumors[M]. Lyon: IARC, 2005: 290-291. [2] Naruse T, Yanamoto S, Sakamoto Y, et al.Clinicopathological study of primary intraosseous squamous cell carcinoma of the jaw and a review of the literature[J]. J Oral Maxillofac Surg, 2016, 74(12): 2420-2427. [3] Woolgar JA, Triantafyllou A, Ferlito A, et al.Intraosseous carcinoma of the jaws: a clinicopathologic review. Part Ⅲ: Primary intraosseous squamous cell carcinoma[J]. Head Neck, 2013, 35(6): 906-909. [4] Liao C, Chang JT, Wang HM, et al.Survival in squamous cell carcinoma of the oral cavity : differences between pT4 N0 and other stage IVA categories[J]. Cancer, 2007, 110(3): 564-571. [5] Bodner L, Manor E, Shear M, et al.Primary intraosseous squamous cell carcinoma arising in an odontogenic cyst: a clinicopathologic analysis of 116 reported cases[J]. J Oral Pathol Med, 2011, 40(10): 733-738. [6] Huang JW, Luo HY, Li Q, et al.Primary intraosseous squamous cell carcinoma of the jaws. Clinicopathologic presentation and prognostic factors[J]. Arch Pathol Lab Med, 2009, 133(11): 1834-1840. [7] Li K, Yang L, Qiao YJ, et al.Risk factors and prognosis for the primary intraosseous carcinoma of the jaw[J]. Int J Oral Maxillofac Surg, 2019, 48(2):157-162. [8] Xu WG, Shen H, Qi XF, et al.Prognostic factors of primary intraosseous squamous cell carcinoma (PIOSCC): a retrospective review[J]. PLoS One, 2016, 11(4): e0153646. [9] Shen Q, Chen Y, Gokavarapu S, et al.Primary intraosseous squamous cell carcinoma of the mandible: locoregional control and survival is significantly reduced if the tumour is more than 4 cm in size[J]. Br J Oral Maxillofac Surg, 2018, 56(1): 48-53. [10] de Morais EF, Carlan LM, de Farias Morais HG, et al. Primary intraosseous squamous cell carcinoma involving the jaw bones: a systematic review and update[J]. Head Neck Pathol, 2021, 15(2): 608-616. [11] Ye P, Wei T, Gao Y, et al.Primary intraosseous squamous cell carcinoma arising from an odontogenic keratocyst: case series and literature review[J]. Med Oral Patol Oral Cir Bucal, 2021, 26(1): e49-e55. [12] Amit M, Na'ara S, Leider-Trejo L, et al. Improving the rate of negative margins after surgery for oral cavity squamous cell carcinoma: a prospective randomized controlled study[J]. Head Neck, 2016, 38(suppl1): E1803-E1809. [13] 贺智凤, 蒲玉梅, 胡勤刚. 口腔鳞状细胞癌切缘状态评估及其影响因素分析[J]. 中华口腔医学杂志, 2017, 52(7): 445-449. He ZF, Pu YM, Hu QG.Evaluation and influencing factors of surgical margin status of oral squamous cell carcinoma[J]. Chinese Journal of Stomatology, 2017, 52(7): 445-449. [14] Nomura T, Monobe H, Tamaruya N, et al.Primary intraosseous squamous cell carcinoma of the jaw: two new cases and review of the literature[J]. Eur Arch Otorhinolaryngol, 2013, 270(1): 375-379. [15] Cohen EEW, Baru J, Huo D, et al.Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy[J]. Head Neck, 2009, 31(8): 1013-1021. [16] 尚伟, 郑家伟. 口腔及口咽癌新版TNM分期与NCCN诊治指南部分解读[J]. 中国口腔颌面外科杂志, 2018, 16(6): 533-546. Shang W, Zheng JW.Interpretation of the new TNM classification and the NCCN guidelines for cancers of the oral cavity and oropharynx[J]. China Journal of Oral and Maxillofacial Surgery, 2018, 16(6): 533-546. [17] Pfister DG, Spencer S, Adelstein D, et al.Head and neck cancers, Version 2.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2020, 18(7): 873-898. |